Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy

被引:817
|
作者
Yu, Frank H.
Mantegazza, Massimo
Westenbroek, Ruth E.
Robbins, Carol A.
Kalume, Franck
Burton, Kimberly A.
Spain, William J.
McKnight, G. Stanley
Scheuer, Todd
Catterall, William A. [1 ]
机构
[1] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA
[3] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
[4] Inst Neurol Besta, Dept Neurophysiol, I-20126 Milan, Italy
基金
加拿大健康研究院;
关键词
D O I
10.1038/nn1754
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Voltage-gated sodium channels (Na-V) are critical for initiation of action potentials. Heterozygous loss-of-function mutations in Na(V)1.1 channels cause severe myoclonic epilepsy in infancy (SMEI). Homozygous null Scn1a(-/-) mice developed ataxia and died on postnatal day (P) 15 but could be sustained to P17.5 with manual feeding. Heterozygous Scn1a(+/-) mice had spontaneous seizures and sporadic deaths beginning after P21, with a notable dependence on genetic background. Loss of Na(V)1.1 did not change voltage-dependent activation or inactivation of sodium channels in hippocampal neurons. The sodium current density was, however, substantially reduced in inhibitory interneurons of Scn1a(+/-) and Scn1a(-/-) mice but not in their excitatory pyramidal neurons. An immunocytochemical survey also showed a specific upregulation of Na(V)1.3 channels in a subset of hippocampal interneurons. Our results indicate that reduced sodium currents in GABAergic inhibitory interneurons in Scn1a(+/-) heterozygotes may cause the hyperexcitability that leads to epilepsy in patients with SMEI.
引用
收藏
页码:1142 / 1149
页数:8
相关论文
共 50 条
  • [31] Antiepileptic drugs for the treatment of severe myoclonic epilepsy in infancy
    Brigo, Francesco
    Storti, Monica
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (11):
  • [32] SEVERE MYOCLONIC EPILEPSY IN INFANCY - A LONGITUDINAL-STUDY
    NIETO, M
    CALANDRE, EP
    CANDAU, R
    RUFO, M
    RUIZPORTAL, R
    CORREA, A
    EPILEPSIA, 1995, 36 : S205 - S205
  • [33] Towards an optimal treatment of severe myoclonic epilepsy in infancy
    Ceulemans, B
    Boel, M
    Claes, L
    Dom, L
    Willekens, H
    Roelens, F
    Thiry, P
    Lagae, L
    EPILEPSIA, 2004, 45 : 193 - 193
  • [34] Paroxysmal movement disorders in severe myoclonic epilepsy in infancy
    Ohtsuka, Y
    Ohmori, I
    Ogino, T
    Ouchida, M
    Shimizu, K
    Oka, E
    BRAIN & DEVELOPMENT, 2003, 25 (06): : 401 - 405
  • [35] Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy
    Iannetti, Paola
    Parisi, Pasquale
    Spalice, Alberto
    Ruggieri, Martino
    Zara, Federico
    EPILEPSY RESEARCH, 2009, 85 (01) : 89 - 95
  • [36] Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy
    Genmaro, E
    Santorelli, FM
    Bertini, E
    Buti, D
    Gaggero, R
    Gobbi, G
    Lini, M
    Granata, T
    Freri, E
    Parmeggiani, A
    Striano, P
    Veggiotti, P
    Cardinali, S
    Bricarelli, FD
    Minetti, C
    Zara, F
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 341 (02) : 489 - 493
  • [37] Hyperinsulinism and hyperammonaemia syndrome and severe myoclonic epilepsy of infancy
    Perez Errazquin, F.
    Sempere Fernandez, J.
    Garcia Martin, G.
    Chamorro Munoz, M. I.
    Romero Acebal, M.
    NEUROLOGIA, 2011, 26 (04): : 248 - 252
  • [38] Severe myoclonic epilepsy in infancy: Toward an optimal treatment
    Ceulemans, B
    Boel, M
    Claes, L
    Dom, L
    Willekens, H
    Thiry, P
    Lagae, L
    JOURNAL OF CHILD NEUROLOGY, 2004, 19 (07) : 516 - 521
  • [39] Sodium channel α1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms
    Wallace, RH
    Hodgson, BL
    Grinton, BE
    Gardiner, RM
    Robinson, R
    Rodriguez-Casero, V
    Sadleir, L
    Morgan, J
    Harkin, LA
    Dibbens, LM
    Yamamoto, T
    Andermann, E
    Mulley, JC
    Berkovic, SF
    Scheffer, IE
    NEUROLOGY, 2003, 61 (06) : 765 - 769
  • [40] Clinical and molecular genetics of myoclonic-astatic epilepsy and severe myoclonic epilepsy in infancy (Dravet syndrome)
    Scheffer, IE
    Wallace, R
    Mulley, JC
    Berkovic, SF
    BRAIN & DEVELOPMENT, 2001, 23 (07): : 732 - 735